ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Comparative efficacy and safety of pharmacological regimens for Mycobacterium avium complex pulmonary disease and bacteremia: A systematic review with separate network meta-analyses

Study limitation reported by the research below: “Substantial heterogeneity in treatment-success outcomes across both MAC-PD and MAC bacteremia networks limits the precision and generalizability of rankings.”

Papers